Uterine Myoma: Optimization of Management and Immunomodulating Therapy
DOI:
https://doi.org/10.51699/ijhsms.v1i4.232Keywords:
uterine fibroids, humoral immune responseAbstract
This article presents the results of studies of 37 women with uterine fibroids. Studies show the positive efficacy of T-life, used as an immunocorrective treatment for uterine fibroids.
Downloads
Download data is not yet available.
Downloads
Published
2022-10-28
Issue
Section
Articles
How to Cite
Uterine Myoma: Optimization of Management and Immunomodulating Therapy. (2022). INTERNATIONAL JOURNAL OF HEALTH SYSTEMS AND MEDICAL SCIENCES, 1(4), 284-289. https://doi.org/10.51699/ijhsms.v1i4.232
